Longboard Pharmaceuticals Stock Probability of Future Stock Price Finishing Over 32.75

LBPH Stock  USD 18.25  0.95  4.95%   
Longboard Pharmaceuticals' future price is the expected price of Longboard Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Longboard Pharmaceuticals performance during a given time horizon utilizing its historical volatility. Check out Longboard Pharmaceuticals Backtesting, Longboard Pharmaceuticals Valuation, Longboard Pharmaceuticals Correlation, Longboard Pharmaceuticals Hype Analysis, Longboard Pharmaceuticals Volatility, Longboard Pharmaceuticals History as well as Longboard Pharmaceuticals Performance.
For more detail on how to invest in Longboard Stock please use our How to Invest in Longboard Pharmaceuticals guide.
  
The Longboard Pharmaceuticals' current Price Earnings To Growth Ratio is estimated to increase to 0.55, while Price Earnings Ratio is projected to decrease to (2.64). Please specify Longboard Pharmaceuticals' target price for which you would like Longboard Pharmaceuticals odds to be computed.

Longboard Pharmaceuticals Target Price Odds to finish over 32.75

The tendency of Longboard Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 32.75  or more in 90 days
 18.25 90 days 32.75 
near 1
Based on a normal probability distribution, the odds of Longboard Pharmaceuticals to move over $ 32.75  or more in 90 days from now is near 1 (This Longboard Pharmaceuticals probability density function shows the probability of Longboard Stock to fall within a particular range of prices over 90 days) . Probability of Longboard Pharmaceuticals price to stay between its current price of $ 18.25  and $ 32.75  at the end of the 90-day period is more than 93.0 .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.11 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Longboard Pharmaceuticals will likely underperform. Additionally Longboard Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
   Longboard Pharmaceuticals Price Density   
       Price  

Predictive Modules for Longboard Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Longboard Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Longboard Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
13.6417.9222.20
Details
Intrinsic
Valuation
LowRealHigh
12.5416.8221.10
Details
Naive
Forecast
LowNextHigh
14.6918.9723.26
Details
7 Analysts
Consensus
LowTargetHigh
15.8617.4319.35
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Longboard Pharmaceuticals. Your research has to be compared to or analyzed against Longboard Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Longboard Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Longboard Pharmaceuticals.

Longboard Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Longboard Pharmaceuticals is not an exception. The market had few large corrections towards the Longboard Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Longboard Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Longboard Pharmaceuticals within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
-0.37
β
Beta against NYSE Composite2.11
σ
Overall volatility
1.98
Ir
Information ratio -0.07

Longboard Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Longboard Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Longboard Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Longboard Pharmaceuticals generated a negative expected return over the last 90 days
Longboard Pharmaceuticals has high historical volatility and very poor performance
Longboard Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (54.42 M) with profit before overhead, payroll, taxes, and interest of 0.
Longboard Pharmaceuticals currently holds about 87.42 M in cash with (50.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.09.
Longboard Pharmaceuticals has a frail financial position based on the latest SEC disclosures
Roughly 64.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: Longboard Pharmaceuticals Receives Overweight Rating from Cantor Fitzgerald - Defense World

Longboard Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Longboard Stock often depends not only on the future outlook of the current and potential Longboard Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Longboard Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding22.7 M
Cash And Short Term Investments48.5 M

Longboard Pharmaceuticals Technical Analysis

Longboard Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Longboard Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Longboard Pharmaceuticals. In general, you should focus on analyzing Longboard Stock price patterns and their correlations with different microeconomic environments and drivers.

Longboard Pharmaceuticals Predictive Forecast Models

Longboard Pharmaceuticals' time-series forecasting models is one of many Longboard Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Longboard Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Longboard Pharmaceuticals

Checking the ongoing alerts about Longboard Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Longboard Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Longboard Pharmaceuticals generated a negative expected return over the last 90 days
Longboard Pharmaceuticals has high historical volatility and very poor performance
Longboard Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (54.42 M) with profit before overhead, payroll, taxes, and interest of 0.
Longboard Pharmaceuticals currently holds about 87.42 M in cash with (50.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.09.
Longboard Pharmaceuticals has a frail financial position based on the latest SEC disclosures
Roughly 64.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: Longboard Pharmaceuticals Receives Overweight Rating from Cantor Fitzgerald - Defense World
When determining whether Longboard Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Longboard Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Longboard Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Longboard Pharmaceuticals Stock:

Complementary Tools for Longboard Stock analysis

When running Longboard Pharmaceuticals' price analysis, check to measure Longboard Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Longboard Pharmaceuticals is operating at the current time. Most of Longboard Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Longboard Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Longboard Pharmaceuticals' price. Additionally, you may evaluate how the addition of Longboard Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Transaction History
View history of all your transactions and understand their impact on performance
Is Longboard Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Longboard Pharmaceuticals. If investors know Longboard will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Longboard Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.39)
Return On Assets
(0.58)
Return On Equity
(1.06)
The market value of Longboard Pharmaceuticals is measured differently than its book value, which is the value of Longboard that is recorded on the company's balance sheet. Investors also form their own opinion of Longboard Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Longboard Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Longboard Pharmaceuticals' market value can be influenced by many factors that don't directly affect Longboard Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Longboard Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Longboard Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Longboard Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.